TI
GRTS

Trexquant Investment’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Trexquant Investment’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,554
Closed -$170K – 1591
2020
Q2 		$170K Buy
+25,554
New +$172K 0.01% 1070

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's GRTS Position: Q3 2020 in Review

Trexquant Investment sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2020, closing a stake of 25,554 shares — an estimated $170K sold.

Trexquant Investment first reported a position in GRTS in Q2 2020 and held it in 1 quarter. The position peaked at $170K in Q2 2020. 69 funds tracked by Wall St. Rank hold GRTS as of Q3 2020.

  • Trexquant Investment reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Trexquant Investment sold 25,554 Gritstone bio, Inc. Common Stock shares in Q3 2020, an estimated $170K.
  • Trexquant Investment first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Trexquant Investment's Gritstone bio, Inc. Common Stock position peaked at $170K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2020.

Based on Trexquant Investment's 13F filing for Q3 2020, filed 6 Nov 2020.